Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug
Brain Sciences · 20.01.2024 · 14 (1) · 103
DOI: 10.3390/brainsci14010103 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 20.01.2024. Verfasst von Liliana Dell'Osso und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, 67 Via Roma, 56126 Pisa, Italy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 253 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The current literature globally highlights the efficacy of Clozapine in several psychiatric disorders all over the world, with an FDA indication for reducing the risk of repeated suicidal behavior in patients with schizophrenia or schizoaffective disorder. A growing field of research is also stressing a possible broader beneficial effect of Clozapine in promoting neuroprotection and neurotrophism. However, this drug is linked to several life-threatening side effects, such as agranulocytosis, myocarditis and seizures, that limit its use in daily clinical practice. For this work, a search was performed on PubMed using the terms “Clozapine indications”, “Clozapine adverse effects”, “Clozapine regenerative effects”, and “Clozapine neuroplasticity” with the aim of reviewing the scientific literature on Clozapine’s treatment indications, adverse effects and potential regenerative role. The results confirmed the efficacy of clozapine in clinical practice, although limited by its adverse effects. It appears crucial to raise awareness among clinicians about the potential benefits of using Clozapine, as well educating medical personnel about its risks and the early identification of possible adverse effects and their management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, 67 Via Roma, 56126 Pisa, Italy.
ORCID-Profile: Benedetta Nardi, Stefano Pini
Zitieren
APA
Dell'Osso, L., Bonelli, C., Nardi, B., Giovannoni, F., Pronestì, C., Cremone, I. M., Amatori, G., Pini, S., & Carpita, B. (2024). Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug. Brain Sciences, 14(1), 103. https://doi.org/10.3390/brainsci14010103
Vancouver
Dell'Osso L, Bonelli C, Nardi B, Giovannoni F, Pronestì C, Cremone IM, et al. Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug. Brain Sciences. 2024;14(1):103. doi:10.3390/brainsci14010103
BibTeX
@article{DellOsso2024,
author = {Dell'Osso, Liliana and Bonelli, Chiara and Nardi, Benedetta and Giovannoni, Federico and Pronestì, Cristiana and Cremone, Ivan Mirko and Amatori, Giulia and Pini, Stefano and Carpita, Barbara},
title = {Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug},
journal = {Brain Sciences},
year = {2024},
volume = {14},
number = {1},
pages = {103},
doi = {10.3390/brainsci14010103}
}
EUVIMED